Skip to content

Clinical promotion and evaluation study of ABC antihypertensive programme for chronic disease management based on Chinese medicine characteristic therapy

Clinical promotion and evaluation study of ABC antihypertensive programme for chronic disease management based on Chinese medicine characteristic therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001728
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive

Interventions

Use group:Regular use of blood pressure management ABCAPP for =2 months
Control group:Failure to use the APP regularly

Sponsors

Jining Hospital of Xiyuan Hospital of CACMS
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Between the ages of 18-65 years male and female; (2) Meet the diagnostic criteria for primary hypertension; (3) Use conventional western medicine treatment at the time of enrollment and can control the blood pressure below 160mmHg/100mmHg; (4) Participants need to have good motor and balance ability and be able to successfully complete the movements related to Baduanjin and acupressure; (5) Informed consent and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who do not have the conditions for APP installation or cannot use the APP for self-management on their own; (2) Those who cannot regularly test their own blood pressure; (3) Patients with serious mental illness: including but not limited to schizophrenia bipolar disorder major depression post-traumatic stress disorder etc. who need to be diagnosed by a psychiatrist and are receiving treatment. Patients with malignant tumors: including those who are receiving chemotherapy radiotherapy and other related treatments. Patients with other major diseases: including but not limited to cirrhosis of the liver end-stage renal disease and other diseases that seriously affect physical function; (4) Patients whose ear skin is damaged to the extent that they are unable to complete ear acupressure; (5) Patients who are allergic to the ingredients in the tea replacement drink; (6) Those who in the opinion of the investigator are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Average morning resting blood pressure;

Secondary

MeasureTime frame
home blood pressure changes;cardiovascular events;compliance rates;Office blood pressure changes ;

Countries

China

Contacts

Public ContactQinghua Shang

Jining Hospital of Xiyuan Hospital of CACMS

y15753729769@126.com15753729769

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026